<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: external beam radiation</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>First study ever to analyze 25 years of data after radiation therapy for prostate cancer patients</title>
   	 <description>The March 2013 issue of The Journal of Urology, the official journal of The American Urological Association, includes a study conducted by four physicians from Radiotherapy Clinics of Georgia (RCOG), a Vantage Oncology affiliate. This study, 25 Year Disease Free Survival Rate after Irradiation of Prostate Cancer Calculated with the Prostate Specific Antigen Definition of Recurrence Used for Radical Prostatectomy, is the first-ever to analyze 25 years of follow-up data after radiation therapy treatment for prostate cancer patients.</description>
     <link>http://medicalxpress.com/news/2013-02-years-therapy-prostate-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 27 Feb 2013 11:10:03 EST</pubDate>
	 <guid isPermaLink="false">news281184022</guid>
	 
</item>
<item>
     <title>Stigma stymies prostate cancer screening, treatment in Ghana</title>
   	 <description>Infectious diseases in Ghana tend to capture the most attention, but a quiet crisis may soon take over as the country's most threatening epidemic: cancer.</description>
     <link>http://medicalxpress.com/news/2013-01-stigma-stymies-prostate-cancer-screening.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 24 Jan 2013 16:35:22 EST</pubDate>
	 <guid isPermaLink="false">news278267715</guid>
	 
</item>
<item>
     <title>Researchers develop prostate cancer testing, treatment guidelines</title>
   	 <description>Julio M. Pow-Sang, M.D., chair of Moffitt Cancer Center's Department of Genitourinary Oncology, and colleagues have published two prostate cancer articles in the September issue of JNCCN – The Journal of the National Comprehensive Cancer Network. The articles review and clarify recent updates made to the National Comprehensive Cancer Network's (NCCN) guidelines for the screening and treatment of prostate cancer.</description>
     <link>http://medicalxpress.com/news/2012-09-prostate-cancer-treatment-guidelines.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 29 Sep 2012 05:29:21 EST</pubDate>
	 <guid isPermaLink="false">news268115353</guid>
	 
</item>
<item>
     <title>Predicting erectile dysfunction from prostate cancer treatment</title>
   	 <description>Researchers have identified 12 DNA sequences that may help doctors determine which men will suffer from erectile dysfunction (ED) following radiation therapy for prostate cancer. Identifying these patients in advance of treatment may better inform men and their families as to which prostate cancer treatments are best for their specific cancer and lifestyle, according to a study to be published online September 27, 2012, in advance of the October 1, 2012 print issue, in the International Journal of Radiation Oncology.Biology.Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). The findings could also guide doctors in recommending the most effective treatments that carry the least risk of patients developing ED.</description>
     <link>http://medicalxpress.com/news/2012-09-erectile-dysfunction-prostate-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 27 Sep 2012 00:00:01 EST</pubDate>
	 <guid isPermaLink="false">news267895572</guid>
	 
</item>
<item>
     <title>Standard radiation therapy dose provides pain relief for painful heel spurs</title>
   	 <description>Patients with plantar fasciitis (painful bone heel spur) experience significantly less pain and improved quality of life following a standard dose of external beam radiation therapy, a common cancer treatment similar to receiving an X-ray, according to a randomized, cooperative group study that was published online July 25, 2012, in the International Journal of Radiation, Oncology, Biology, Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).</description>
     <link>http://medicalxpress.com/news/2012-07-standard-therapy-dose-pain-relief.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 27 Jul 2012 10:34:15 EST</pubDate>
	 <guid isPermaLink="false">news262604050</guid>
	 
</item>
<item>
     <title>Prostate cancer treatment regret is 52 percent higher in men with cardiovascular disease</title>
   	 <description>Prostate cancer patients with cardiovascular disease were 52 per cent more likely to regret their treatment choices than men without problems with their heart or veins, according to a study published in the July issue of the urology journal BJUI International.</description>
     <link>http://medicalxpress.com/news/2012-07-prostate-cancer-treatment-percent-higher.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 02 Jul 2012 11:07:44 EST</pubDate>
	 <guid isPermaLink="false">news260446056</guid>
	 
</item>
<item>
     <title>Researchers find sarcoma tumor immune response with combination therapy</title>
   	 <description>A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells) and fractionated external beam radiation (EBRT) provided more than 50 percent of their trial patients with tumor-specific immune responses lasting from 11 to 42 weeks.</description>
     <link>http://medicalxpress.com/news/2012-03-sarcoma-tumor-immune-response-combination.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 01 Mar 2012 11:29:14 EST</pubDate>
	 <guid isPermaLink="false">news249823745</guid>
	 
</item>
<item>
     <title>Newer radiation technology improves head and neck cancer patients' long-term quality of life</title>
   	 <description>Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.</description>
     <link>http://medicalxpress.com/news/2012-01-technology-neck-cancer-patients-long-term.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 26 Jan 2012 09:58:57 EST</pubDate>
	 <guid isPermaLink="false">news246794319</guid>
	 
</item>
<item>
     <title>Brachytherapy reduced death rates in high-risk prostate cancer patients, study finds</title>
   	 <description>Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise. A population-based analysis looking at almost 13,000 cases revealed that men who received brachytherapy alone or in combination with external beam radiation therapy (EBRT) had significantly reduced mortality rates.</description>
     <link>http://medicalxpress.com/news/2012-01-brachytherapy-death-high-risk-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 25 Jan 2012 17:00:27 EST</pubDate>
	 <guid isPermaLink="false">news246733218</guid>
	 
</item>
<item>
     <title>Proton therapy effective prostate cancer treatment</title>
   	 <description>Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies published in the January issue of the International Journal of Radiation Oncology&amp;#149;Biology&amp;#149;Physics (Red Journal), the American Society for Radiation Oncology's (ASTRO) official scientific journal.</description>
     <link>http://medicalxpress.com/news/2012-01-proton-therapy-effective-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 05 Jan 2012 16:56:10 EST</pubDate>
	 <guid isPermaLink="false">news245004850</guid>
	 
</item>
<item>
     <title>Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy</title>
   	 <description>Accelerated partial breast irradiation using brachytherapy (APBIb) for the treatment of breast cancer has been rapidly increasing over the last several years in the U.S. as an alternative to standard whole-breast irradiation (WBI), according to a study published December 16th in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-12-advantages-uncertain-brachytherapy-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 16 Dec 2011 17:42:02 EST</pubDate>
	 <guid isPermaLink="false">news243279712</guid>
	 
</item>
<item>
     <title>Higher radiation dose does not help lung cancer patients live longer</title>
   	 <description>A higher dose of radiation (74 Gy) does not improve overall survival for non-small cell lung cancer that has spread to the lymph nodes, compared to the standard radiation dose (60 Gy), according to an interim analysis of a late-breaking randomized study presented at the plenary session, October 3, 2011, at the 53rdAnnual Meeting of the American Society for Radiation Oncology (ASTRO).</description>
     <link>http://medicalxpress.com/news/2011-10-higher-dose-lung-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 03 Oct 2011 12:36:17 EST</pubDate>
	 <guid isPermaLink="false">news236864165</guid>
	 
</item>
<item>
     <title>IMRT has less harmful rectal side effects than 3D-CRT for prostate cancer patients</title>
   	 <description>Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved lower dose of radiation to the bladder and rectum, compared to those who undergo 3D-CRT, according to a randomized study presented at the plenary session October 3, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology (ASTRO).</description>
     <link>http://medicalxpress.com/news/2011-09-imrt-rectal-side-effects-3d-crt.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 26 Sep 2011 13:36:22 EST</pubDate>
	 <guid isPermaLink="false">news236262973</guid>
	 
</item>
<item>
     <title>Emerging trends in radiation therapy for women over 70 with early stage breast cancer</title>
   	 <description>Patterns of radiation usage in breast conserving therapy for women 70 years and older with stage I breast cancer are changing: more women are opting for radioactive implants and those with estrogen positive tumors are opting out of radiation therapy, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jefferson University Hospital researchers on Saturday, June 4. The abstract (#6094) received an ASCO Merit Award.</description>
     <link>http://medicalxpress.com/news/2011-06-emerging-trends-therapy-women-early.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 Jun 2011 17:26:54 EST</pubDate>
	 <guid isPermaLink="false">news226254381</guid>
	 
</item>
<item>
     <title>ASTRO publishes evidence-based guideline for thoracic radiotherapy</title>
   	 <description>The American Society for Radiation Oncology (ASTRO) has developed a guideline for the use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused by advanced lung cancer. The guideline will be published in Practical Radiation Oncology, an official journal of ASTRO.</description>
     <link>http://medicalxpress.com/news/2011-04-astro-publishes-evidence-based-guideline-thoracic.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 27 Apr 2011 13:31:48 EST</pubDate>
	 <guid isPermaLink="false">news223129893</guid>
	 
</item>


</channel>
</rss>
